Avalo Therapeutics Down Nearly 40%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk
Dow Jones2026/10/22 15:05Avalo Therapeutics Inc. (AVTX) is currently at $7.36, down $4.90 or 39.97%
--Would be lowest close since July 30, 2025, when it closed at $6.66
--On pace for largest percent decrease since June 26, 2023, when it fell 88.69%
--Currently down two consecutive days; down 40.45% over this period
--Worst two day stretch since the two days ending Sept. 18, 2023, when it fell 42.6%
--Down 51.99% month-to-date
--Down 59.47% year-to-date; on pace for worst year since 2023, when it fell 99.25%
--Down 99.96% from its all-time closing high of $20793.61 on Feb. 27, 2019
--Down 58.93% from 52 weeks ago (Oct. 23, 2025), when it closed at $17.92
--Down 67.82% from its 52-week closing high of $22.87 on May 7, 2026
--Would be a new 52-week closing low
--Traded as low as $6.85; lowest intraday level since July 31, 2025, when it hit $6.57
--Down 44.13% at today's intraday low; largest intraday percent decrease since June 26, 2023, when it fell as much as 88.69%
All data as of 11:02:46 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 22, 2026 11:05 ET (15:05 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline
Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.
Japan's core CPI rose 2.1% year-on-year in September, surpassing the central bank's 2% target for the first time in nine months! Broadening inflation strengthens expectations of a near-term rate hike.
Data released on Friday showed that Japan’s core Consumer Price Index (CPI) rose by 2.1% year-on-year in September, exceeding the Bank of Japan’s 2% inflation target for the first time in nine months. This indicates that price pressures are spreading and reinforces market expectations of an interest rate hike in the near future.
Heatbit launches a new home water heater that can mine Bitcoin
DoubleLine Capital: Large-Scale Borrowing and Weak Demand Will Continue to Put Pressure, Still Bearish on Long-Term U.S. Treasuries
DoubleLine Capital Deputy Chief Investment Officer Jeffrey Sherman stated that he remains bearish on long-term U.S. Treasury bonds, believing that large-scale government borrowing and weak demand will continue to put pressure on the U.S. Treasury market.
